Replies to post #112 on Acorda Therapeutics Inc (ACORQ)

[surf1944]

News BreaksJune 28, 2012 09:22 EDT ACOR
theflyonthewall.com: Acorda Therapeutics shares should be bought on recent weakness, says RBC Capital
After speaking with Acorda's management, RBC Capital predicts that the Street will have growing interest in a Phase III study of the company's stroke treatment. The firm thinks that the treatment could reinforce the company's status as a takeover target and it maintains a $38 target and Outperform rating on the shares.